MedKoo Cat#: 555118 | Name: LYS228

Description:

WARNING: This product is for research use only, not for human or veterinary use.

LYS228, also known as Ancremonam, is a potent antibiotics with Activity against Carbapenem-Resistant Enterobacteriaceae (MIC90 = 2 uM/mL). LYS228 is potent in the presence of all classes of beta-lactamases and shows potent activity against carbapenem-resistant isolates of Enterobacteriaceae (CRE).

Chemical Structure

LYS228
LYS228
CAS#1810051-96-7 (free acid)

Theoretical Analysis

MedKoo Cat#: 555118

Name: LYS228

CAS#: 1810051-96-7 (free acid)

Chemical Formula: C16H18N6O10S2

Exact Mass: 518.0526

Molecular Weight: 518.47

Elemental Analysis: C, 37.07; H, 3.50; N, 16.21; O, 30.86; S, 12.37

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
2091840-41-2 (sodium) 1810051-96-7 (free acid) 2091840-42-3 (X hydrate) 2091840-43-4 (trihydrate)
Synonym
LYS228; LYS-228; LYS 228; Ancremonam
IUPAC/Chemical Name
1-((((Z)-1-(2-aminothiazol-4-yl)-2-oxo-2-(((3S,4R)-2-oxo-4-((2-oxooxazolidin-3-yl)methyl)-1-sulfoazetidin-3-yl)amino)ethylidene)amino)oxy)cyclopropane-1-carboxylic acid
InChi Key
FWTGYTRQUBRVDW-NRABZWKMSA-N
InChi Code
InChI=1S/C16H18N6O10S2/c17-14-18-7(6-33-14)9(20-32-16(1-2-16)13(25)26)11(23)19-10-8(5-21-3-4-31-15(21)27)22(12(10)24)34(28,29)30/h6,8,10H,1-5H2,(H2,17,18)(H,19,23)(H,25,26)(H,28,29,30)/b20-9-/t8-,10+/m1/s1
SMILES Code
O=C1[C@@H](NC(/C(C2=CSC(N)=N2)=N\OC3(CC3)C(O)=O)=O)[C@@H](CN4CCOC4=O)N1S(=O)(O)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Metallo--lactamases (MBLs), such as New Delhi metallo--lactamase (NDM-1) have spread world-wide and present a serious threat. Expression of MBLs confers resistance in Gram-negative bacteria to all classes of -lactam antibiotics, with the exception of monobactams, which are intrinsically stable to MBLs. However, existing first generation monobactam drugs like aztreonam have limited clinical utility against MBL-expressing strains because they are impacted by serine -lactamases (SBLs), which are often co-expressed in clinical isolates.

Preparing Stock Solutions

The following data is based on the product molecular weight 518.47 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Klingen AR, Palsdottir H, Hunte C, Ullmann GM. Redox-linked protonation state changes in cytochrome bc1 identified by Poisson-Boltzmann electrostatics calculations. Biochim Biophys Acta. 2007 Mar;1767(3):204-21. Epub 2007 Jan 31. PubMed PMID: 17349966. 2: Rosell A, Valencia E, Ochoa WF, Fita I, Parés X, Farrés J. Complete reversal of coenzyme specificity by concerted mutation of three consecutive residues in alcohol dehydrogenase. J Biol Chem. 2003 Oct 17;278(42):40573-80. Epub 2003 Aug 4. PubMed PMID: 12902331. 3: Rosell A, Valencia E, Parés X, Fita I, Farrés J, Ochoa WF. Crystal structure of the vertebrate NADP(H)-dependent alcohol dehydrogenase (ADH8). J Mol Biol. 2003 Jun 27;330(1):75-85. PubMed PMID: 12818203. 4: Shimizu T, Nakatsu T, Miyairi K, Okuno T, Kato H. Active-site architecture of endopolygalacturonase I from Stereum purpureum revealed by crystal structures in native and ligand-bound forms at atomic resolution. Biochemistry. 2002 May 28;41(21):6651-9. PubMed PMID: 12022868. 5: Swamy-Mruthinti S, Schey KL. Mass spectroscopic identification of in vitro glycated sites of MIP. Curr Eye Res. 1997 Sep;16(9):936-41. PubMed PMID: 9288456. 6: Hacker B, Barquera B, Gennis RB, Crofts AR. Site-directed mutagenesis of arginine-114 and tryptophan-129 in the cytochrome b subunit of the bc1 complex of Rhodobacter sphaeroides: two highly conserved residues predicted to be near the cytoplasmic surface of putative transmembrane helices B and C. Biochemistry. 1994 Nov 8;33(44):13022-31. PubMed PMID: 7947707. 7: Hurley TD, Bosron WF, Stone CL, Amzel LM. Structures of three human beta alcohol dehydrogenase variants. Correlations with their functional differences. J Mol Biol. 1994 Jun 10;239(3):415-29. PubMed PMID: 8201622. 8: Shilton BH, Campbell RL, Walton DJ. Site specificity of glycation of horse liver alcohol dehydrogenase in vitro. Eur J Biochem. 1993 Aug 1;215(3):567-72. PubMed PMID: 8354263.